Our year in review

Neuroblastoma Australia's 2022-2023 Annual Report provides a summary of what we achieved, the impact we've made and how we worked towards our mission to find safer and more effective treatments for the devastating childhood cancer neuroblastoma.

Thanks to the dedication of our supporters we will have invested over $3.1 million in research by 2023 however, we continue to be a small charity, mindful of costs but focused on developing further to reach our goal – better, safer, kinder treatments for neuroblastoma.

Read the latest report

• Neuroblastoma Australia Annual Report 2022 - 2023
• Neuroblastoma Australia Annual Report 2021 - 2022
• Neuroblastoma Australia Annual Report 2020 - 2021
• Neuroblastoma Australia Annual Report 2019 - 2020
• Neuroblastoma Australia Annual Report 2018 - 2019

Financials

Neuroblastoma Australia was a volunteer charity until 2016 donating 100% of proceeds to research. In 2016 the charity took on the challenge of growing and developing with the ambition of raising more funds. The charity employed people for the first time and has invested in improving overall resources and skills to be able to achieve its mission more effectively.

The charity’s main costs are the event costs which however provide the bulk of fundraising. Please refer to our audited Financial Reports below.

We are delighted to have the services of Moore Stephens accountants to support our finance operations.

• 2021 Financials
• 2020 Financials
• 2019 Financials
• 2018 Financials
• 2017 Financials
• 2016 Financials

More information

• Our purpose
• Our story
• Our families
• Our events
• Current research projects
• Grant recipients